Getting blacklisted by the federal government is generally not the kind of pre-IPO momentum a company hopes for. But Anthropic, the AI company behind Claude, appears to be turning what could have been a deal-killer into a diplomatic reset.
The White House and Anthropic are actively working to de-escalate a standoff that erupted earlier this year, when the company refused to let the US military deploy its AI models for domestic surveillance or fully autonomous weapons systems. The government’s response was swift: it classified Anthropic as a national security supply-chain risk. Now, with a confidential IPO filing reportedly submitted around June 1, 2026, and a potential valuation reaching $1 trillion, both sides have strong incentives to play nice.
How we got here
The rift between Anthropic and the Trump administration traces back to a fundamental disagreement about what AI should and shouldn’t do. Anthropic drew a hard line against allowing Claude to be used in certain military applications, specifically domestic surveillance and autonomous weaponry. Washington’s response was to designate Anthropic a supply-chain risk earlier in 2026, making it harder for federal agencies and their contractors to do business with the company.
The turning point came in mid-April 2026, when CEO Dario Amodei made a visit to the White House. That meeting appears to have opened a channel for productive dialogue after months of tension. Since then, Anthropic’s leadership has been in heightened discussions with multiple government agencies, including the White House and the Department of the Treasury.
Anthropic hasn’t rolled over, though. The company is simultaneously challenging its blacklisting through legal channels, contesting the supply-chain risk designation in court.
The IPO that could reshape AI markets
The confidential IPO filing, projected for around June 1, 2026, targets a valuation as high as $1 trillion. Anthropic’s path to public markets also puts it in a cohort with other massive private tech companies like OpenAI and SpaceX, both of which have been navigating their own complex relationships with regulators and government agencies.
What this means for investors
The supply-chain risk designation is worth watching closely. Even as diplomatic channels improve, the legal challenge is still active. Investors should pay attention to whether the designation gets formally lifted before the IPO or whether Anthropic goes public while still technically on the blacklist.
The risk that deserves attention is what happens if the détente doesn’t hold. Anthropic’s IPO prospectus will almost certainly flag regulatory risk as a material concern, and for a company seeking a trillion-dollar valuation, how investors price that risk carries implications measured in hundreds of billions of dollars.